CL

Colgate-Palmolive Company: Q2 2024 10-Q Summary

Business Context and Reporting Period

This summary covers the quarterly period ended June 30, 2024. Colgate-Palmolive operates in two primary segments: Oral, Personal and Home Care and Pet Nutrition (Hill's). The company competes in over 200 countries, with approximately two-thirds of net sales generated outside the U.S. and 45% from emerging markets. The company is a large accelerated filer with 817 million shares of common stock outstanding as of June 30, 2024.

Key Financial Metrics

Material Changes vs. Prior Period

• Sales Growth: Q2 2024 net sales increased 4.9% year-over-year, driven by volume growth of 4.7% and net selling price increases of 4.2%, partially offset by a 4.1% negative foreign exchange impact. Organic sales growth was 9.0%.
• Profitability: Operating profit rose 12% to $1,092M. Gross margin expanded 280 basis points to 60.6%, aided by cost savings from "funding-the-growth" initiatives and pricing, offset by higher raw material costs.
• Expense Management: SG&A expenses increased 10% to $1,939M, primarily due to a $105M increase in advertising investment. Operating profit margin improved 140 basis points to 21.6%.
• Segment Performance:
  • Latin America: Strongest organic sales growth at 18.8% (driven by Argentina, Brazil, Mexico) and operating profit up 15%.
  • Pet Nutrition: Sales up 5.5% with operating profit up 23%.
  • North America: Sales up 2.5%; operating profit declined slightly 2% due to higher advertising and overhead expenses.
• Restructuring: The company incurred $27M in pretax charges related to the "2022 Global Productivity Initiative" in Q2 2024. Cumulative charges for the initiative reached $205M as of June 30, 2024.

Guidance, Outlook, and Risks

• Outlook: Management expects global macroeconomic conditions to remain challenging due to inflation, high interest rates, and foreign currency volatility. Pricing actions have been taken to offset cost increases but may negatively impact consumer demand.
• Geopolitical Risks: The war in Ukraine and the Israel-Hamas war continue to impact supply chains, logistics, and raw material costs. The company has ceased capital investments in Russia.
• Restructuring Progress: Substantially all initiatives under the 2022 Global Productivity Initiative have been implemented. Remaining charges are expected in the second half of 2024. Total expected pretax charges are approximately $225M, with expected annualized pretax savings of $125M.
• Legal Contingencies:
  • ERISA Litigation: A $267M charge was recorded in Q1 2023 regarding a pension plan amendment. The company is appealing a March 2024 District Court ruling on calculation issues.
  • Talcum Powder: 293 individual cases were pending as of June 30, 2024. Settlements to date have not been material.
  • Brazilian Tax Matters: Ongoing disputes regarding interest deductions and foreign exchange losses totaling approximately $117M in assessments.
• Capital Allocation: The company increased its quarterly dividend to $0.50 per share. Share repurchases totaled $989M in the first six months of 2024.

Key Facts for Investor Verification

• Organic Sales Growth: Verify the 9.0% organic sales growth rate, which excludes foreign exchange impacts that negatively affected reported sales by 4.1%.
• Restructuring Run-Rate: Confirm the timing and magnitude of remaining charges for the 2022 Global Productivity Initiative, expected to be incurred in the second half of 2024.
• Advertising Spend: Monitor the impact of increased advertising investment (up 18% in Q2) on future sales volume and market share.
• Foreign Exchange Exposure: Assess the impact of currency volatility, particularly in hyper-inflationary economies like Argentina and Türkiye, on future earnings.
• Legal Exposure: Track the status of the ERISA appeal and the volume of talcum powder litigation cases, as adverse outcomes could be material.